Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
TEVA News Today | Why did Teva Pharmaceutical Industries stock go down today?
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva sees return to growth after opioid settlement, shares jump | Reuters
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
New York could get $524M under opioid settlements with Teva - ABC News
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva's flagship drug Austedo scores new approval at the FDA
Teva x Sankuanz Team Up for Hurricane Sandal at Opening Ceremony – Footwear News
Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio? | Entrepreneur
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic Times
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Allergan to own 10% stake in Teva
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
teva News and latest stories | The Jerusalem Post
Teva CEO Schultz likely won't renew employment contract: reports
Allergan on $40.5 Billion Drug Deal - The New York Times
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
